Latest Corporate News
Mars Clears $36 Billion Acquisition of Kellanova
Mars and Kellanova have received European Commission approval, with the transaction expected to close on December 11, 2025, pending customary closing conditions, marking a significant consolidation in the food sector.
Alcon Amends Merger Agreement with STAAR Surgical, Increasing Offer Price
Alcon increased its acquisition price for STAAR Surgical by $150 million to a total equity value of $1.6 billion, representing substantial premiums and expects deal closure in early 2026 after shareholder and regulatory approvals.
ProAmpac to Acquire TC Transcontinental Packaging for $1.51 Billion
ProAmpac signed a definitive agreement to acquire TC Transcontinental Packaging from TC Transcontinental in a deal expected to close Q1 2026, subject to shareholder and regulatory approvals.
BioNTech and Bristol Myers Squibb Present Positive Phase 2 Data for Pumitamig
BioNTech and Bristol Myers Squibb announced encouraging efficacy data for their PD-L1xVEGF-A bispecific antibody pumitamig in advanced triple-negative breast cancer, showing promise for patients with limited options.
MergerLinks Releases FY2025 M&A Advisory Firm Rankings
MergerLinks published rankings of top financial and legal advisory firms globally for mergers and acquisitions, highlighting standout firms in a softening market and emphasizing AI-powered tools aiding dealmakers.
DLA Piper Advises StoreDot on Business Combination with Andretti Acquisition Corp II
DLA Piper is advising StoreDot in its business combination transaction announced in early December 2025, which will result in the company being listed on Nasdaq, subject to closing conditions.
U.S. Federal Reserve Expected to Cut Interest Rates by 25 Basis Points
Anticipated Fed decision on December 10, 2025, includes a 25 bps interest rate cut amid concerns over a softening labor market and mixed economic signals.
Trump 2.0 Tariff Tracker Signals Potential Increase to 15-20% Reciprocal Tariffs
President Trump announced intentions to raise baseline reciprocal tariff rates, in a move that may impact trade policies and corporate planning going into 2026.
Adverum Biotechnologies Common Stock to be Suspended Effective December 10, 2025
NASDAQ announced suspension effective December 10, 2025, for Adverum Biotechnologies common stock reflecting corporate actions that may affect shareholders and investors.
U.S. Consumer Confidence Fell Sharply in November 2025, Impacting Corporate Sentiment
Alongside economic indicators noting declines in employment indices and confidence, businesses may face cautious investment climate heading into year-end.